Objectives To systematically review and meta-analyze the prevalence and genetic diversity of rotavirus A (RVA) in humans, animals, and environmental water samples in West Africa and to describe its geographic distribution and circulation patterns.
Methods PubMed, Scopus, Web of Science, African Journals Online, ScienceDirect, SpringerLink, JSTOR, clinical trial registries, and global health libraries were searched for observational studies published from January 1, 2010, to December 20, 2025, reporting molecular RVA genotyping data from West Africa. Two reviewers independently screened studies, extracted data, assessed risk of bias using the Joanna Briggs Institute and SYRCLE tools, and summarized genotype distributions narratively. Random-effects meta-analyses were used to estimate pooled prevalence by source category.
Results Fifty-four studies were included, comprising 21,532 samples and 2,080 RVA-positive cases. The overall pooled prevalence was 12.6% (95% confidence interval [CI], 9.9%–15.6%). Prevalence was highest in animals (19.77%; 95% CI, 5.4%–40.1%), followed by environmental water samples (14.81%; 95% CI, 3.5%–31.1%) and humans (11.37%; 95% CI, 9.0%–14.0%). Overall heterogeneity was very high (I²=97.1%). In human studies, G1P[8], G9P[8], and G2P[4] were among the most frequently detected and geographically widespread genotype combinations.
Conclusion RVA circulates widely in humans, animals, and environmental water samples across West Africa, although evidence is characterized by substantial heterogeneity, uneven geographic representation, and limited animal and environmental water data. These findings support integrated One Health surveillance, monitoring for genotype shifts, and stronger water, sanitation, and hygiene interventions.
Objectives The objectives of this review and meta-analysis were twofold: first, to determine the prevalence of substance use among school-going children in Arab and African countries; and second, to highlight the considerable influence of variables such as the nation’s region and the timeframe of the study on the prevalence of substance use.
Methods Research was sourced from Science Direct, Scopus, Web of Science, Google Scholar, and PubMed. Thirty-seven articles were incorporated in accordance with the PRISMA guidelines. This review included studies published from 2013 to 2023. The statistical meta-analysis was performed using Comprehensive Meta-Analysis ver. 3 software. Across 37 studies, the total number of study participants was 73,508.
Results The meta-analysis revealed that tobacco was the most commonly used substance, with a prevalence of 16% (95% confidence interval [CI], 12.7%–20.02%). This was closely followed by alcohol, which had a prevalence of 15% (95% CI, 10.5%–22.8%), stimulants at 11.4% (95% CI, 7.4%–17%), khat at 10% (95% CI, 5.7%–15%), and cannabis at 8% (95% CI, 3.3%–18.4%). Notably, alcohol was the only substance that showed an increasing trend in prevalence from before to after 2019, rising from 13.3% (95% CI, 6.2%–26.1%) to 17% (95% CI, 10.2%–27%) (p<0.001). Additionally, the prevalence of substance use varied significantly between Arab and African countries (p<0.001).
Conclusion Although the prevalence of substance use among school-going populations has significantly decreased over time, with the exception of alcohol, it is imperative that both African and Arab countries implement comprehensive measures and stringent laws to address the production and marketing of substances.
Citations
Citations to this article as recorded by
Association of Substance Use Pattern and Family Factors With Use-Related Problems According to Arabic Drug Abuse Screening Test-10: A Cross-Sectional Study Hussam Aly Sayed Murad, Marwan Bakarman Substance Use: Research and Treatment.2026;[Epub] CrossRef
Objectives Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19). The COVID-19 incidence and mortality rates are low in Nigeria compared to global trends. This research mapped the evolution of SARS-CoV-2 circulating in Nigeria and globally to determine whether the Nigerian isolates are genetically distinct from strains circulating in regions of the world with a high disease burden. Methods: Bayesian phylogenetics using BEAST 2.0, genetic similarity analyses, and genomewide mutational analyses were used to characterize the strains of SARS-CoV-2 isolated in Nigeria. Results: SARS-CoV-2 strains isolated in Nigeria showed multiple lineages and possible introductions from Europe and Asia. Phylogenetic clustering and sequence similarity analyses demonstrated that Nigerian isolates were not genetically distinct from strains isolated in other parts of the globe. Mutational analysis demonstrated that the D614G mutation in the spike protein, the P323L mutation in open reading frame 1b (and more specifically in NSP12), and the R203K/ G204R mutation pair in the nucleocapsid protein were most prevalent in the Nigerian isolates. Conclusion: The SARS-CoV-2 strains in Nigeria were neither phylogenetically nor genetically distinct from virus strains circulating in other countries of the world. Thus, differences in SARS-CoV-2 genomes are not a plausible explanation for the attenuated COVID-19 outcomes in Nigeria.
Citations
Citations to this article as recorded by
COVID19 Sero-epidemiology and vaccine uptake in two Southern Nigerian clinics Chinedu A. Ugwu, Ooreofe Odebode, Israel O. Ajayi, Josiah Olubunmi, Bejide Ifeoluwa, Jolly A. Adole, Kazeem Akano, Johnson Okolie, Philomena Eromon, Imonikhe K. Kio, Judith Amadi, Precious F. Adebayo, Iheanyi Mgbeokwere, Akeem O. Lawal, Olayemisi A. Adego PLOS Global Public Health.2026; 6(3): e0006126. CrossRef
A retrospective whole genome sequencing of SARS-CoV-2 isolate from respiratory sample of an individual from Ota – Ogun State, Nigeria Olajumoke Olufunmilayo Joseph, Samuel Olatunde Dahunsi, Anthony Okoh Gene Reports.2024; 37: 102032. CrossRef
<sec>
<title>Objectives</title>
<p>This study aimed to extend an epidemiological model (SEIHFR) to analyze epidemic trends, and evaluate intervention efficacy.</p></sec>
<sec>
<title>Methods</title>
<p>SEIHFR was modified to examine disease transmission dynamics after vaccination for the Ebola outbreak. Using existing data from Liberia, sensitivity analysis of various epidemic scenarios was used to inform the model structure, estimate the basic reproduction number ℜ<sub>0</sub> and investigate how the vaccination could effectively change the course of the epidemic.</p></sec>
<sec>
<title>Results</title>
<p>If a randomized mass vaccination strategy was adopted, vaccines would be administered prophylactically or as early as possible (depending on the availability of vaccines). An effective vaccination rate threshold for Liberia was estimated as 48.74% among susceptible individuals. If a ring vaccination strategy was adopted to control the spread of the Ebola virus, vaccines would be given to reduce the transmission rate improving the tracing rate of the contact persons of an infected individual.</p></sec>
<sec>
<title>Conclusion</title>
<p>The extended SEIHFR model predicted the total number of infected cases, number of deaths, number of recoveries, and duration of outbreaks among others with different levels of interventions such as vaccination rate. This model may be used to better understand the spread of Ebola and develop strategies that may achieve a disease-free state.</p></sec>
Citations
Citations to this article as recorded by
Fear effect on the corruption dynamics of a mathematical differential equation SECJH model Mingyong Pan, Zhifu Xie Communications in Nonlinear Science and Numerical .2026; 156: 109621. CrossRef
Identifiability analysis of an HIV-Ebola co-infection using the mathematical model and the MLE method Muhammad Said, Yunil Roh, Il Hyo Jung Alexandria Engineering Journal.2025; 125: 245. CrossRef
Analysis of the First Three Waves of COVID‐19 in West Africa Using an Epidemic Model With Different Modes of Transmission Muhammad Said, Wasim Abbas, Yunil Roh, Il Hyo Jung, Tao Zhou Complexity.2025;[Epub] CrossRef
How mathematical modelling can inform outbreak response vaccination Manjari Shankar, Anna-Maria Hartner, Callum R. K. Arnold, Ezra Gayawan, Hyolim Kang, Jong-Hoon Kim, Gemma Nedjati Gilani, Anne Cori, Han Fu, Mark Jit, Rudzani Muloiwa, Allison Portnoy, Caroline Trotter, Katy A. M. Gaythorpe BMC Infectious Diseases.2024;[Epub] CrossRef
A secure data fitting scheme based on CKKS homomorphic encryption for medical IoT Yunxuan Su, Xu An Wang, Weidong Du, Yu Ge, Kaiyang Zhao, Ming Lv Journal of High Speed Networks.2023; 29(1): 41. CrossRef
Risk-averse multi-stage stochastic programming to optimizing vaccine allocation and treatment logistics for effective epidemic response Xuecheng Yin, İ Esra Büyüktahtakın IISE Transactions on Healthcare Systems Engineerin.2022; 12(1): 52. CrossRef
Model-based evaluation of the impact of prophylactic vaccination applied to Ebola epidemics in Sierra Leone and Democratic Republic of Congo Ravi Potluri, Amit Kumar, Valérie Oriol-mathieu, Thierry Van Effelterre, Laurent Metz, Hitesh Bhandari BMC Infectious Diseases.2022;[Epub] CrossRef
A hybrid simulation model to study the impact of combined interventions on Ebola epidemic Peiyu Chen, Wenhui Fan, Xudong Guo, Constantinos Siettos PLOS ONE.2021; 16(7): e0254044. CrossRef
Transmission dynamics of the COVID‐19 outbreak and effectiveness of government interventions: A data‐driven analysis Yaqing Fang, Yiting Nie, Marshare Penny Journal of Medical Virology.2020; 92(6): 645. CrossRef
Impact of prophylactic vaccination strategies on Ebola virus transmission: A modeling analysis Ravi Potluri, Amit Kumar, Vikalp Maheshwari, Charlie Smith, Valerie Oriol Mathieu, Kerstin Luhn, Benoit Callendret, Hitesh Bhandari, Malaya Kumar Sahoo PLOS ONE.2020; 15(4): e0230406. CrossRef
Modeling the 2014–2015 Ebola Virus Disease Outbreaks in Sierra Leone, Guinea, and Liberia with Effect of High- and Low-risk Susceptible Individuals Qianying Lin, Salihu S. Musa, Shi Zhao, Daihai He Bulletin of Mathematical Biology.2020;[Epub] CrossRef